Adaptimmune Therapeutics
ADAP
#10376
Rank
A$20.4 M
Marketcap
A$0.07699
Share price
0.00%
Change (1 day)
-81.04%
Change (1 year)

Financial Reports

Thumbnail Adaptimmune Therapeutics Financial Report 2022

Financial Report 2022

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2021

Financial Report 2021

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2020

Financial Report 2020

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2019

Financial Report 2019

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2018

Financial Report 2018

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2017

Financial Report 2017

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2016

Financial Report 2016

Language: English

View Financial Report